Navigation Links
Accuray Reports Financial Results for First Quarter of Fiscal Year 2014
Date:11/7/2013

SUNNYVALE, Calif., Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the first fiscal quarter ended September 30, 2013.
Results are presented on a GAAP basis, unless otherwise indicated, as the magnitude of purchase accounting amortization was minimal for fiscal year 2013 and is projected to be minimal for fiscal year 2014 and beyond, making GAAP results comparable on a year over year basis and a good measure of the company's performance.

First Quarter and Recent Highlights

  • Continued strong order momentum with gross orders of $63.4 million, an increase of 17% from the first fiscal quarter of 2013.
  • Gross profit margins improve 590 basis points, operating expenses decline 13% and adjusted EBITDA improves $8.1 million, all compared to the prior year first fiscal quarter.
  • Over 100 oral and poster presentations at the 55th annual American Society for Radiation Oncology (ASTRO) meeting reinforcing clinical and quality of life benefits for the CyberKnife® and TomoTherapy® Systems.
  • "We had a strong start to the fiscal year with most elements of our performance being above our expectations, reflecting strong commercial and operational execution.  Orders into backlog are being driven by the actions we have taken to improve our commercial focus and enable growth through improved business processes.  We expect that product revenues will begin to strengthen over the next several quarters as well," said Joshua H. Levine, president and chief executive officer of Accuray.  "Improving gross profit margins along with continued expense control in narrowing our adjusted EBITDA losses puts the business on a strong trajectory to achieve profitability, along with higher revenues."

    "We are enthusiastic about fiscal 2014 and the continued execution improvem
    '/>"/>

    SOURCE Accuray Incorporated
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
    2. Accuray Announces First CyberKnife System in South America
    3. Accuray Surpasses 600 Installations Globally
    4. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
    5. Omeros Corporation Reports Third Quarter 2013 Financial Results
    6. Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
    7. Global In Vitro Fertilization Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
    8. Global Biophotonics Market & OSS BSS Industry 2012-2016 Reports
    9. China Vanadium Catalyst Market for Sulfuric Acid Production in A New Research Available at MarketReportsChina.com
    10. Cytos Biotechnology Ltd Reports Third Quarter 2013 Financial Results and Recent Developments
    11. Neurocrine Biosciences Reports Third Quarter 2013 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/21/2015)... April 21, 2015  Scientists from the J. ... organization, published a paper today outlining new synthetic ... called diatoms. The researchers, led by first author ... Philip Weyman , Ph.D., conclude that these ... of diatom genetics and thus facilitate advances in ...
    (Date:4/21/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced ... of MM-141, a bispecific antibody targeting IGF-1R and ErbB3.  ... Dr. Mansoor Saleh , MD at the 2015 ... Philadelphia, PA.  The trial evaluated the ... in combination with everolimus or with nab-paclitaxel and gemcitabine ...
    (Date:4/21/2015)... , April 21, 2015 Ampio Pharmaceuticals, ... a scheduled investor call on Thursday, April 23, 4:30 ... the instructions as follows: Investor call ... number: (844) 789-4877 International toll number: (925) 418-7845 Participant ... advance to Tina Amirkiai , tina.amirkiai@fleishman.com . ...
    (Date:4/21/2015)... , April 21, 2015  Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... that Dr. Mark W. Sawicki , ... 3rd Annual BioLogistics Summit in San ...
    Breaking Biology Technology:Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. ET 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3
    ... being lifted from the once unseen world of molecular activity. ... and scientists were forced to gauge the processes behind those ... that approach have become clear with the advent of technologies ... A prime example is the recent first ever direct observations ...
    ... , SAN DIEGO, Aug. 7 ... sales of products for the diagnosis and treatment of coronary and ... the Canaccord Adams 29th Annual Global Growth Conference on Thursday, August ... president and chief executive officer, will begin at 11:30 a.m., Eastern ...
    ... , CORAL GABLES, Fla., Aug. 7 Catalyst Pharmaceutical ... second quarter and six months ended June 30, 2009. , , ... For the quarter ended June 30, 2009, the Company reported a ... a net loss of $2,377,440, or $0.19 per basic and diluted share for ...
    Cached Biology Technology:Growth spurts 2Growth spurts 3Growth spurts 4Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 7
    (Date:4/1/2015)... Medisafe ™, the leading global medication management platform with ... Android smartphones and tablets, announces today that ... allow patients to track and correlate their adherence directly ... be able to visualize in real-time how taking medication ... glucose levels and blood pressure. "Patients need ...
    (Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
    (Date:3/23/2015)... 23, 2015   HOYOS Labs , a leading ... announced that the Company will demonstrate multiple biometrics-based technologies ... consumers at Connect:ID on March 23 through 25, 2015, ... will highlight the IEEE Biometric Open Protocol Standard; free ... enterprise access control system. BOPS was invented by HOYOS ...
    Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
    ... of a TB Vaccine PDP, An Exhibitor,s Workshop at the ... 1:00-2:00 PM VENUE: 2011 AAAS ANNUAL MEETING, ,WASHINGTON CONVENTION ... an overview of the state of the global TB epidemic ... product development partnerships such as Aeras; and ways that scientists ...
    ... kingdom was overgrown by vines when she fell into a ... University of Wisconsin at Milwaukee received more than a million ... real vines are overtaking the American tropics. Data from eight ... "We are witnessing a fundamental structural change in the physical ...
    ... a human cell and a bacterial cell met at a ... numbers, much less genetic material. In more scientific terms, a ... to bacteria. Until now. Northwestern Medicine researchers have discovered ... bacterial genome in this case, Neisseria gonorrhoeae , ...
    Cached Biology News:Why are vines overtaking the American tropics? 2Gonorrhea acquires a piece of human DNA 2
    ... regulate cell stretching or compression of a ... Computer controlled so you can precisely regulate ... to produce 64 unique strain parameters. ST-160 ... ST-150. Both models are compatible with Nikon, ...
    ... EasyCount ViaSure Kit is used in conjunction with ... nucleated cells automatically. The ViaSure Staining Reagent ... - Acridine Orange and Ethidium Bromide to identify ... test, while the EasyCount Slide 6 Multi-well ...
    ... Basic power supply are used for electrophoretic blotting ... accommodates two 7.5 x 10 cm gels and ... Bio-Ice cooling unit, buffer tank, lid with power ... power supply, 100-120 and 220-240 V, provides output ...
    ...
    Biology Products: